Opella has become the first global consumer healthcare company to achieve B Corp certification, after meeting the rigorous social and environmental standards set by nonprofit B Lab.
Opella has officially launched as an independent company, following the successful closing of a transaction in which global investment firm CD&R acquired a 50 per cent controlling stake from Sanofi.
